TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26657900

Group type: EXPERIMENTAL
Intervention: Split-Dose Group (SDG) - low-volume 2-L polyethylene glycol (PEG)-ascorbate solution in a 'split-dose' regimen
Number of subjects: 690

Group type: COMPARATOR
Intervention: Day-Before Group (DBG) - traditional 'full-dose, day-before' regimen
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: Split-Dose Group (SDG)
Number of subjects: 690

Group type: COMPARATOR
Intervention: Day-Before Group (DBG)
Number of subjects: 690
Study: 26021558

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone marrow mononuclear cells within 24 hours (group A, n = 27)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone marrow mononuclear cells 3 to 7 days after PCI (group B, n = 26)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (n = 25) - saline infusion performed immediately after emergency PCI
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone marrow mononuclear cells 7 to 30 days after PCI (group C, n = 26)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone marrow mononuclear cells within 24 hours (group A)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone marrow mononuclear cells 3 to 7 days after PCI (group B)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone marrow mononuclear cells 7 to 30 days after PCI (group C)
Number of subjects: 104
Study: 23819670

Group type: EXPERIMENTAL
Intervention: Short-term group psychotherapy
Number of subjects: 0
Study: 21421664

Group type: EXPERIMENTAL
Intervention: 24-day NOMAC/E2 regimen
Number of subjects: 77

Group type: COMPARATOR
Intervention: 21-day NOMAC/E2 regimen
Number of subjects: 77
Study: 18797670

Group type: COMPARATOR
Intervention: CAT and placebo eyedrops (PED)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: CAT, 0.015% MMC subconjunctivally, and PED
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: CAT and 0.02% MMC eyedrops
Number of subjects: 29
Study: 14763319

Group type: EXPERIMENTAL
Intervention: Mathematical method for evaluating labor progress
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pretest-posttest analysis
Number of subjects: 0
Study: 11239222

Group type: EXPERIMENTAL
Intervention: Amifostine (500 mg single dose)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No amifostine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Amifostine
Number of subjects: 40
Study: 9727725

Group type: EXPERIMENTAL
Intervention: Vitamin E 600 mg per day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vitamin E 1600 mg per day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (unchanged medication)
Number of subjects: 20
Study: 8281696

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Recombinant tissue‐type plasminogen activator
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Patency of the infarct‐related artery (TIMI 3 flow)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Occlusion score (amount of myocardium supplied by an occluded artery)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Ejection fraction > or = 50%
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Ejection fraction < 50%
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Treadmill exercise duration 4 weeks after infarction
Number of subjects: 312
Study: 2735560

Group type: EXPERIMENTAL
Intervention: Evening primrose oil
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 29

Group type: COMPARATOR
Intervention: Olive oil (placebo)
Number of subjects: 29
Study: 21750157

Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (hGH), 20 μg/kg/day
Number of subjects: 712

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 712
Study: 31928085

Group type: EXPERIMENTAL
Intervention: Lip and soft palate closure at 3 to 4 months and hard palate closure at 12 months (arm A)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Lip and hard palate closure at 3 to 4 months and soft palate closure at 12 months (arm D)
Number of subjects: 136
Study: 30975155

Group type: EXPERIMENTAL
Intervention: Aboriginal Identification in Hospitals Quality Improvement Program (AIHQIP)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no AIHQIP implementation)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: AIHQIP
Number of subjects: 8
Study: 29871262

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy and radiotherapy
Number of subjects: 190

Group type: COMPARATOR
Intervention: Concurrent radiotherapy and chemotherapy plus adjuvant chemotherapy
Number of subjects: 190
Study: 26160958

Group type: EXPERIMENTAL
Intervention: Extended-release nicotinic acid
Number of subjects: 8
Study: 23256145

Group type: EXPERIMENTAL
Intervention: Whole milk intake (≥237 mL/d or 1 serving/d)
Number of subjects: 21660

Group type: EXPERIMENTAL
Intervention: Whole milk intake
Number of subjects: 21660

Group type: EXPERIMENTAL
Intervention: Skim/low-fat milk intake
Number of subjects: 21660

Group type: EXPERIMENTAL
Intervention: Total dairy products intake (>2.5 servings/d)
Number of subjects: 21660
Study: 21489301

Group type: EXPERIMENTAL
Intervention: H. pylori eradication
Number of subjects: 92

Group type: COMPARATOR
Intervention: H. pylori-negative or indeterminate
Number of subjects: 92
Study: 19893969

Group type: EXPERIMENTAL
Intervention: Essential oil‐containing mouthrinse (EO)
Number of subjects: 159

Group type: COMPARATOR
Intervention: 0.05% CPC with alcohol (CPCa)
Number of subjects: 159

Group type: COMPARATOR
Intervention: 0.05% CPC alcohol‐free (CPCna)
Number of subjects: 159

Group type: COMPARATOR
Intervention: 5% hydroalcohol negative control
Number of subjects: 159
Study: 16467972

Group type: EXPERIMENTAL
Intervention: School curriculum-based exercise intervention program (40 minutes/school day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (60 minutes physical activity/week)
Number of subjects: 53
Study: 15849392

Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (n=22)
Number of subjects: 96

Group type: COMPARATOR
Intervention: No antenatal corticosteroids (n=74)
Number of subjects: 96
Study: 10958572

Group type: EXPERIMENTAL
Intervention: HoLRP
Number of subjects: 120

Group type: COMPARATOR
Intervention: TURP
Number of subjects: 120
Study: 9311396

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 169

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 169
Study: 8348110

Group type: EXPERIMENTAL
Intervention: Nabumetone (1,000 mg once daily)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Piroxicam (20 mg once daily)
Number of subjects: 198
Study: 3789368

Group type: EXPERIMENTAL
Intervention: Buccal morphine 10 mg tablets
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intramuscular morphine sulphate 13.5 mg
Number of subjects: 50
Study: 29346249

Group type: EXPERIMENTAL
Intervention: 1% lignocaine
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: 2% lignocaine
Number of subjects: 500

Group type: COMPARATOR
Intervention: Comparison of 1% vs 2% lignocaine
Number of subjects: 500
Study: 27447721

Group type: EXPERIMENTAL
Intervention: Sugar-free beverage (250 mL per day) for 18 months
Number of subjects: 477
Study: 24332142

Group type: EXPERIMENTAL
Intervention: Full prescription coverage with adherence (proportion of days covered ≥80%) to statin, β-blocker, or angiotensin-converting enzyme inhibitor/angiotensin receptor blocker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonadherent patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Partially adherent patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 22418773

Group type: EXPERIMENTAL
Intervention: Neratinib 240 mg once daily (QD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Neratinib 120 mg twice daily (BID)
Number of subjects: 50
Study: 20532178

Group type: EXPERIMENTAL
Intervention: Atazanavir/ritonavir with tenofovir-emtricitabine
Number of subjects: 148

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir with tenofovir-emtricitabine
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: NRTI TDRs
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: NNRTI TDRs
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Multiple TAMs
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: M184V/I
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: PI TDRs
Number of subjects: 148
Study: 17934715

Group type: EXPERIMENTAL
Intervention: Arthroscopic ACL reconstruction with Delta plasty using hamstrings as auto-grafts
Number of subjects: 41
Study: 16126738

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 97
Study: 11929644

Group type: EXPERIMENTAL
Intervention: 30 microg ethinyl estradiol + 2 mg dienogest (30 EE/DNG)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 20 microg ethinyl estradiol + 2 mg dienogest (20 EE/DNG)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 10 microg ethinyl estradiol + 2 mg estradiol valerate + 2 mg dienogest (EE/EV/DNG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: 20 microg ethinyl estradiol + 100 microg levonorgestrel (EE/LNG)
Number of subjects: 100
Study: 10384247

Group type: EXPERIMENTAL
Intervention: Biofeedback (12 sessions of 1/2 hr duration)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Progressive relaxation (6 sessions of 1 hr each)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Self-monitoring control group (10 children)
Number of subjects: 50
Study: 8588965

Group type: EXPERIMENTAL
Intervention: H1 and H2-receptor-blocking agents in standard dosages preoperatively (Antihistamine group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No histamine-receptor-blocking agents (Control group)
Number of subjects: 30
Study: 2650532

Group type: EXPERIMENTAL
Intervention: Visible light-cured material
Number of subjects: 52

Group type: COMPARATOR
Intervention: Chemically cured adhesive
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Overall analysis of all adhesive/base combinations
Number of subjects: 52
Study: 1089400

Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-tryptophan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30772189

Group type: EXPERIMENTAL
Intervention: Eccentric hamstring training (ECC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Concentric hamstring training (CON)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30
Study: 28681626

Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray (100, 200, 400, 600, 800 mcg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray (400, 600, 800 mcg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray (600, 800 mcg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fentanyl citrate IV
Number of subjects: 50
Study: 25123256

Group type: EXPERIMENTAL
Intervention: 1-set combined exercise protocol (30 min of aerobic exercise at 65-70% of reserve heart rate and 1 set of 8-12 repetitions at 80% of 10-RM in six resistance exercises)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 3-sets combined exercise protocol (same as 1-set but with 3 sets)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control session (30 min of seated rest)
Number of subjects: 16
Study: 23439692

Group type: EXPERIMENTAL
Intervention: Culturally tailored diabetes prevention program (intervention group)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 58

Group type: COMPARATOR
Intervention: Healthy living diabetes prevention presentations
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Weekly reminder calls and homework assignments
Number of subjects: 58
Study: 21909495

Group type: EXPERIMENTAL
Intervention: Xeno IV (self-etch adhesive)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: XP Bond (etch-and-rinse adhesive)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Adper‐Scotchbond SE (etch-and-rinse adhesive)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Etch-and-rinse systems
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-etching systems
Number of subjects: 40
Study: 19578819

Group type: EXPERIMENTAL
Intervention: Full apology and acceptance of responsibility
Number of subjects: 200

Group type: COMPARATOR
Intervention: No apology and no responsibility
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Perceived apology and responsibility
Number of subjects: 200
Study: 16510637

Group type: EXPERIMENTAL
Intervention: Combined pneumococcal conjugate and polysaccharide vaccinations
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccinations
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group (no additional vaccination)
Number of subjects: 161
Study: 12775969

Group type: EXPERIMENTAL
Intervention: Treprostinil infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 16451393

Group type: EXPERIMENTAL
Intervention: Oral deferiprone (L1)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Subcutaneous desferrioxamine (DF)
Number of subjects: 36
Study: 10891831

Group type: EXPERIMENTAL
Intervention: Coping skills training (CST) combined with intensive diabetes management (IDM)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Coping skills training (CST)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Intensive diabetes management (IDM) alone
Number of subjects: 77
Study: 8654655

Group type: EXPERIMENTAL
Intervention: Large loop excision of the transformation zone of the cervix
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no cervical surgery)
Number of subjects: 33
Study: 2068599

Group type: EXPERIMENTAL
Intervention: ZDV (experimental anti-HIV drug)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 40
Study: 6340975

Group type: EXPERIMENTAL
Intervention: 200 micrograms salbutamol 4-hourly
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 200 micrograms salbutamol 2-hourly
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31939564

Group type: EXPERIMENTAL
Intervention: Transcutaneous tibial nerve stimulation (TTNS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Transcutaneous parasacral stimulation
Number of subjects: 50
Study: 27730298

Group type: EXPERIMENTAL
Intervention: Remote monitoring using the GEx System (intervention group, IG)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Conventional cardiac rehabilitation (control group, CG)
Number of subjects: 118
Study: 27221319

Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids (ACS) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no ACS intervention)
Number of subjects: 0
Study: 24132855

Group type: EXPERIMENTAL
Intervention: Support from specialist healthcare services during the last 6 months of life
Number of subjects: 2444

Group type: EXPERIMENTAL
Intervention: Links with external healthcare providers (GP, palliative care nurses, physiotherapy)
Number of subjects: 2444

Group type: EXPERIMENTAL
Intervention: Dependency of residents
Number of subjects: 2444
Study: 22302355

Group type: EXPERIMENTAL
Intervention: Clinical Decision Support System (CDSS)
Number of subjects: 424
Study: 20626053

Group type: EXPERIMENTAL
Intervention: Japanese Magnetic Pearls
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Vaccaria seeds
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (tape treatment only)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 84
Study: 17142247

Group type: EXPERIMENTAL
Intervention: Self-completed agenda form (SCAF)
Number of subjects: 3124

Group type: COMPARATOR
Intervention: Control group (no SCAF)
Number of subjects: 3124
Study: 16335045

Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cetrexidin
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Tubulicid Plus
Number of subjects: 100

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 100
Study: 12517329

Group type: EXPERIMENTAL
Intervention: Continuous infusion of low-dose dopamine (3 microg/kg/min)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Furosemide 5 mg/hr infusion
Number of subjects: 80

Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 80

Group type: COMPARATOR
Intervention: Low-dose dopamine
Number of subjects: 80
Study: 9658737

Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation
Number of subjects: 32
Study: 7660061

Group type: EXPERIMENTAL
Intervention: Tinnitus patients with normal hearing or slight hearing loss
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Tinnitus patients with moderate to pronounced sensorineural hearing loss
Number of subjects: 113

Group type: COMPARATOR
Intervention: Controls (220 matched individuals)
Number of subjects: 113
Study: 2486945

Group type: EXPERIMENTAL
Intervention: Flame Test
Number of subjects: 116

Group type: COMPARATOR
Intervention: Crystallography
Number of subjects: 116
Study: 31796061

Group type: EXPERIMENTAL
Intervention: Chat-bot with evidence-based contents to help quit smoking
Number of subjects: 460

Group type: COMPARATOR
Intervention: Usual treatment according to the protocol for tobacco cessation by the Madrid Regional Health Service
Number of subjects: 460
Study: 28865441

Group type: EXPERIMENTAL
Intervention: Intraarticular corticosteroid injections
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Psychometric parameters (Pseudoneurology subscale in SHC)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Being female
Number of subjects: 105
Study: 25092528

Group type: EXPERIMENTAL
Intervention: Pre-exhaustion training (n = 14)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Same exercise order with a rest interval between exercises (n = 17)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (n = 8) performing exercises in a different order (compound exercises prior to isolation)
Number of subjects: 39
Study: 22430092

Group type: EXPERIMENTAL
Intervention: New operation group (n=453)
Number of subjects: 969

Group type: COMPARATOR
Intervention: Conventional group (n=516)
Number of subjects: 969
Study: 19220519

Group type: EXPERIMENTAL
Intervention: Educational intervention on Ni-Ti rotary system in Intervention County (IC)
Number of subjects: 195

Group type: COMPARATOR
Intervention: No educational intervention in Control County (CC)
Number of subjects: 195
Study: 17913754

Group type: EXPERIMENTAL
Intervention: 1 MAC sevoflurane administered via the ventilator for 15 min followed by a 15 min washout before CPB
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no sevoflurane administration)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 1 MAC sevoflurane
Number of subjects: 72
Study: 16131559

Group type: EXPERIMENTAL
Intervention: Tidal volume of 6 ml/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tidal volume of 12 ml/kg
Number of subjects: 0
Study: 11866252

Group type: EXPERIMENTAL
Intervention: Standard naltrexone plus low-value contingency management (CM)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Standard naltrexone plus high-value contingency management (CM)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard naltrexone treatment
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Standard naltrexone plus low-value CM
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Standard naltrexone plus high-value CM
Number of subjects: 55
Study: 10361962

Group type: EXPERIMENTAL
Intervention: Moclobemide 450 mg per day
Number of subjects: 135

Group type: COMPARATOR
Intervention: Clomipramine 150 mg per day
Number of subjects: 135
Study: 8963358

Group type: EXPERIMENTAL
Intervention: Short-bout exercise group (SB, n = 28)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Long-bout exercise group (LB, n = 28)
Number of subjects: 56
Study: 1723407

Group type: EXPERIMENTAL
Intervention: Current chemotherapy for advanced testicular cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New regimens evaluated in randomized trials
Number of subjects: 0
Study: 7258824

Group type: EXPERIMENTAL
Intervention: 0.5% FPL‐55712 (SRS‐A antagonist)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 1% FPL‐55712 (SRS‐A antagonist)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31955502

Group type: EXPERIMENTAL
Intervention: More experienced abstractors
Number of subjects: 50

Group type: COMPARATOR
Intervention: Less experienced abstractors
Number of subjects: 50
Study: 31629764

Group type: EXPERIMENTAL
Intervention: Continuous BFR (cBFR)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intermittent BFR (iBFR)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low-load RE without BFR (LI)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Traditional high-load RE (HI)
Number of subjects: 14
Study: 27779809

Group type: EXPERIMENTAL
Intervention: Perinatal probiotics (Lactobacillus rhamnosus GG, Bifidobacterium lactis Bb‐12, Lactobacillus paracasei ST11, Bifidobacterium longum BL999)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Perinatal probiotics (general)
Number of subjects: 303
Study: 26105008

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline (CON)
Number of subjects: 7
Study: 23534456

Group type: EXPERIMENTAL
Intervention: Higher-GI carbohydrates
Number of subjects: 21955

Group type: EXPERIMENTAL
Intervention: Lower-GI carbohydrates
Number of subjects: 21955

Group type: EXPERIMENTAL
Intervention: Replacement of saturated and trans-fatty acids with carbohydrates
Number of subjects: 21955

Group type: EXPERIMENTAL
Intervention: Replacement of MUFA with carbohydrates
Number of subjects: 21955
Study: 20522167

Group type: EXPERIMENTAL
Intervention: SQ and IV insulin therapy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 17
Study: 19270234

Group type: EXPERIMENTAL
Intervention: Continuous peritoneal dialysis (CPD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Daily hemodialysis (dHD)
Number of subjects: 120
Study: 17365745

Group type: EXPERIMENTAL
Intervention: d,l-fenfluramine
Number of subjects: 593

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 593